Azathioprine in Chronic Recalcitrant Erythema Nodosum Leprosum: A Case Report

Erythema Nodosum Leprosum (ENL) may have a chronic course which may be recalcitrant to treatment. Preferred treatment modalities are systemic corticosteroids and thalidomide. Azathioprine, methotrexate and cyclosporine are immunosuppressants which may also be used as a steroid sparing agent. We re...

Full description

Bibliographic Details
Main Authors: Singh Shailendra Vikram Jitendra, Romita Bachaspatimayum, A. Subhalakshmi Devi, S. Rita
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2017-08-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
Online Access:https://jcdr.net/articles/PDF/10499/26536_CE(RA1)_F(T)_PF1_(SY_MJ_PY)_PFA(SY_SS).pdf
_version_ 1819064638973673472
author Singh Shailendra Vikram Jitendra
Romita Bachaspatimayum
A. Subhalakshmi Devi
S. Rita
author_facet Singh Shailendra Vikram Jitendra
Romita Bachaspatimayum
A. Subhalakshmi Devi
S. Rita
author_sort Singh Shailendra Vikram Jitendra
collection DOAJ
description Erythema Nodosum Leprosum (ENL) may have a chronic course which may be recalcitrant to treatment. Preferred treatment modalities are systemic corticosteroids and thalidomide. Azathioprine, methotrexate and cyclosporine are immunosuppressants which may also be used as a steroid sparing agent. We report the case of a 48-year-old male diagnosed as lepromatous leprosy that developed ENL after four months of Multibacillary Multi-Drug Therapy (MB-MDT). He was treated with oral prednisolone (1 mg/kg/ day) which was gradually tapered upto a dose of 7.5 mg/day. He developed recurrences on and off once the dose reached the said level and this continued for three years. Oral clofazamine (300 mg/day x 6 months; then 100 mg/day x 6 months) was also added in the second year. Thalidomide (200 mg/day) was also given but withdrawn due to adverse effect after 10 days. Azathioprine was started at a dose of 100 mg/day following which there was resolution of symptoms by one week and no recurrences by 10 weeks; it was given for eight months after which the dose was tapered to 50 mg/day for another four months. Complete withdrawal of oral prednisolone after gradual tapering was possible by 12 months of azathioprine therapy. The patient is still on regular follow-up with no recurrences so far till the last check-up.
first_indexed 2024-12-21T15:33:46Z
format Article
id doaj.art-db9c2447b3544cf3b69a5283a67cb2d4
institution Directory Open Access Journal
issn 2249-782X
0973-709X
language English
last_indexed 2024-12-21T15:33:46Z
publishDate 2017-08-01
publisher JCDR Research and Publications Private Limited
record_format Article
series Journal of Clinical and Diagnostic Research
spelling doaj.art-db9c2447b3544cf3b69a5283a67cb2d42022-12-21T18:58:42ZengJCDR Research and Publications Private LimitedJournal of Clinical and Diagnostic Research2249-782X0973-709X2017-08-01118FD01FD0210.7860/JCDR/2017/26536.10499Azathioprine in Chronic Recalcitrant Erythema Nodosum Leprosum: A Case ReportSingh Shailendra Vikram Jitendra0Romita Bachaspatimayum1A. Subhalakshmi Devi2S. Rita3Postgraduate Student, Department of Pharmacology, Regional Institute of Medical Sciences, Imphal, Manipur, India.Assistant Professor, Department of Dermatology, Venereology and Leprosy, Regional Institute of Medical Sciences, Imphal, Manipur, India.Professor, Department of Pharmacology, Regional Institute of Medical Sciences, Imphal, Manipur, India.Professor, Department of Pharmacology, Regional Institute of Medical Sciences, Imphal, Manipur, India.Erythema Nodosum Leprosum (ENL) may have a chronic course which may be recalcitrant to treatment. Preferred treatment modalities are systemic corticosteroids and thalidomide. Azathioprine, methotrexate and cyclosporine are immunosuppressants which may also be used as a steroid sparing agent. We report the case of a 48-year-old male diagnosed as lepromatous leprosy that developed ENL after four months of Multibacillary Multi-Drug Therapy (MB-MDT). He was treated with oral prednisolone (1 mg/kg/ day) which was gradually tapered upto a dose of 7.5 mg/day. He developed recurrences on and off once the dose reached the said level and this continued for three years. Oral clofazamine (300 mg/day x 6 months; then 100 mg/day x 6 months) was also added in the second year. Thalidomide (200 mg/day) was also given but withdrawn due to adverse effect after 10 days. Azathioprine was started at a dose of 100 mg/day following which there was resolution of symptoms by one week and no recurrences by 10 weeks; it was given for eight months after which the dose was tapered to 50 mg/day for another four months. Complete withdrawal of oral prednisolone after gradual tapering was possible by 12 months of azathioprine therapy. The patient is still on regular follow-up with no recurrences so far till the last check-up.https://jcdr.net/articles/PDF/10499/26536_CE(RA1)_F(T)_PF1_(SY_MJ_PY)_PFA(SY_SS).pdfcorticosteroidlepra reactionlepromatous leprosy
spellingShingle Singh Shailendra Vikram Jitendra
Romita Bachaspatimayum
A. Subhalakshmi Devi
S. Rita
Azathioprine in Chronic Recalcitrant Erythema Nodosum Leprosum: A Case Report
Journal of Clinical and Diagnostic Research
corticosteroid
lepra reaction
lepromatous leprosy
title Azathioprine in Chronic Recalcitrant Erythema Nodosum Leprosum: A Case Report
title_full Azathioprine in Chronic Recalcitrant Erythema Nodosum Leprosum: A Case Report
title_fullStr Azathioprine in Chronic Recalcitrant Erythema Nodosum Leprosum: A Case Report
title_full_unstemmed Azathioprine in Chronic Recalcitrant Erythema Nodosum Leprosum: A Case Report
title_short Azathioprine in Chronic Recalcitrant Erythema Nodosum Leprosum: A Case Report
title_sort azathioprine in chronic recalcitrant erythema nodosum leprosum a case report
topic corticosteroid
lepra reaction
lepromatous leprosy
url https://jcdr.net/articles/PDF/10499/26536_CE(RA1)_F(T)_PF1_(SY_MJ_PY)_PFA(SY_SS).pdf
work_keys_str_mv AT singhshailendravikramjitendra azathioprineinchronicrecalcitranterythemanodosumleprosumacasereport
AT romitabachaspatimayum azathioprineinchronicrecalcitranterythemanodosumleprosumacasereport
AT asubhalakshmidevi azathioprineinchronicrecalcitranterythemanodosumleprosumacasereport
AT srita azathioprineinchronicrecalcitranterythemanodosumleprosumacasereport